WANG, XIAOZHAO,王晓钊,王曉釗,CARLSEN, PETER NIELS,卡森 彼得 尼尔斯,卡森 彼得 尼爾斯,GAN, PEI,甘霈,HOANG, GIA,黄 嘉,黃 嘉,LI, YONG,李勇,QI, CHAO,祁超,WU, LIANGXING,吴亮星,吳亮星,YAO, WENQING,姚 文庆,姚 文慶,YU, ZHIYONG,余志勇,ZHU, WE
申请号：
TW108123484
公开号：
TW202012409A
申请日:
2019.07.03
申请国别(地区):
TW
年份:
2020
代理人:
摘要：
This application relates to compounds of Formula (I):,or pharmaceutically acceptable salts thereof, which modulate the activity of adenosine receptors, such as subtypes A2A and A2B receptors, and are useful in the treatment of diseases related to the activity of adenosine receptors including, for example, cancer, inflammatory diseases, cardiovascular diseases, and neurodegenerative diseases.本申請案係關於式(I)化合物，，或其醫藥學上可接受之鹽，其調節腺苷受體、諸如亞型A2A及A2B受體之活性，且可用於治療與腺苷受體之活性有關之疾病，包括例如癌症、發炎性疾病、心血管疾病及神經退化性疾病。
